Health Condition 1: L700- Acne vulgaris Health Condition 2: null- Patients with moderate acne vilgaris
Conditions
Interventions
Intervention1: Anti acne cream: Topical application of anti acne cream twice a day on the affected area for 60 days after washing their face with face wash.
Control Intervention1: NIL: NIL
Sponsors
A Menarini India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1 Male and female patients aged 18 to 50 years, with a diagnosis of moderate facial acne vulgaris 2 Facial inflammatory lesion count > 20 and 3 Non inflammatory lesion count of atleast 20-100. 4 Investigators Global Assessment Score of 3.
Exclusion criteria
Exclusion criteria: 1 Patients with 2 nodulocystic lesions, prior topical acne treatment or systemic anti inflammatory agents in past 14 days. 2 Patients on systemic corticosteroids, antibacterial, immunosuppressant drugs or abrading facial procedures in the past 30 days. 3 Patients with other concurrent facial skin disease and patients who are photosensitive or who are likely to engage in activities that involve excessive or prolonged exposure to sunlight. 4 Patients with drug induced acne. 5 Patients with menopausal disorders. 6 Has a history of significant reactions to topical acne treatments, or a known allergy or hypersensitivity to any listed ingredients. 7 Use of oral retinoids within 6 months of Baseline visit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 Investigators Global Assessment 2 Facial inflammatory and non inflammatory lesion countTimepoint: 1 Investigators Global Assessment 2 Facial inflammatory and non inflammatory lesion count | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Standardized Clinical PhotographsTimepoint: 1 Standardized Clinical Photographs (Baseline and Day 45) | — |
Countries
India
Contacts
Public ContactMr Kiran Vuppala
ClinWorld Provate Limited
Outcome results
None listed